Cozaar: Uses, dosage, side effects, warnings & patient reviews

What is Cozaar (Losartan)?

Cozaar, with the generic name losartan potassium, is an angiotensin II receptor blocker (ARB). It works by selectively blocking the action of angiotensin II, a hormone that causes blood vessels to constrict, leading to relaxation of the vessels and a reduction in blood pressure.

This medication is primarily indicated for the treatment of hypertension (high blood pressure). It is also used to reduce the risk of stroke in patients with hypertension and an enlarged heart (left ventricular hypertrophy), and to treat kidney problems caused by type 2 diabetes with hypertension (diabetic nephropathy).

Losartan is metabolized in the liver to an active compound that is responsible for most of its long-term blood pressure-lowering effects. Compared with ACE inhibitors, ARBs such as losartan are less likely to be associated with a persistent dry cough.

How to Take Cozaar

Adherence to prescribed dosing instructions is essential for managing blood pressure effectively and minimizing risks.

Administration

Cozaar tablets are taken orally, usually once or twice daily as directed by a physician. It can be taken with or without food. Consistency in timing is important for maintaining stable drug levels in the body.

For patients who are volume-depleted (e.g., from diuretic therapy), a healthcare provider may initiate therapy with a lower dose to minimize the risk of low blood pressure (hypotension).

Course of Treatment

High blood pressure is a chronic condition often requiring long-term management. Cozaar helps control blood pressure but does not cure the underlying condition. It is important to continue taking the medication even if you feel well. Do not stop taking losartan without consulting your doctor, as blood pressure may increase significantly and raise the risk of complications.

Missed Dose

If a dose is missed, take it as soon as you remember. If it is almost time for the next scheduled dose, skip the missed dose and resume the normal dosing schedule. Do not take a double dose to make up for a missed one.

Side Effects of Cozaar

As with any medication, Cozaar can cause adverse effects. The following table categorizes these effects based on general frequency.

Seek immediate medical attention if you experience symptoms of angioedema or signs of a severe allergic reaction, such as difficulty breathing, hives, or swelling.

What is Cozaar Used For?

Cozaar (losartan) is prescribed for specific, FDA-approved medical conditions related to the cardiovascular and renal systems.

Primary Medical Uses

• Hypertension: Indicated for lowering high blood pressure in adults and pediatric patients 6 years and older.
• Stroke Risk Reduction: Used in patients with hypertension and left ventricular hypertrophy to reduce the risk of stroke. In clinical studies, this benefit was not observed in Black patients with this condition.
• Diabetic Nephropathy: Used in patients with type 2 diabetes and hypertension with protein in the urine. It has been shown to reduce proteinuria and may help slow progression of kidney disease in appropriate patients.

The choice of losartan and its dose for these conditions is determined by a healthcare provider based on a comprehensive patient assessment.

Important Safety Concerns and Considerations

Several specific concerns require monitoring and medical supervision during treatment with Cozaar.

Fetal Toxicity (Pregnancy)

As highlighted in the safety advice, the use of losartan during pregnancy is associated with a Boxed Warning, the FDA’s strongest safety alert. Exposure can reduce fetal kidney function and may lead to serious fetal and neonatal complications, including kidney failure and skeletal effects (including skull hypoplasia), and in some cases fetal death. Patients who could become pregnant should discuss pregnancy planning and contraceptive options with a clinician while taking this medication.

Hyperkalemia (High Blood Potassium)

Losartan can decrease aldosterone secretion, leading to elevated serum potassium. The risk is increased in patients with kidney disease, diabetes, heart failure, or those taking potassium supplements or other drugs that raise potassium. Potassium monitoring may be recommended, as significant hyperkalemia can contribute to clinically important heart rhythm disturbances.

Renal Function Impairment

In patients whose kidney function depends on the activity of the renin-angiotensin system (e.g., those with severe heart failure or renal artery stenosis), treatment with losartan may be associated with oliguria, progressive azotemia, or acute renal failure. Dose-dependent increases in blood urea nitrogen (BUN) and serum creatinine may occur. Renal function should be monitored periodically.

Hypotension in Volume-Depleted Patients

Symptomatic hypotension may occur after initiation of therapy in patients who are volume- or salt-depleted, such as those treated with high-dose diuretics. In these situations, clinicians may correct volume depletion before starting therapy and/or select a lower starting dose.

Critical Warnings for Cozaar Use

Contraindications

Cozaar is contraindicated in patients with known hypersensitivity to losartan or any component of the formulation, and in women who are pregnant. Cozaar is also contraindicated for use with aliskiren in patients with diabetes.

Use in Patients with Impaired Hepatic Function

In patients with hepatic impairment, losartan exposure can be increased. Clinicians may consider a lower starting dose (e.g., 25 mg once daily) based on the clinical situation.

Interaction with Drugs Affecting Blood Pressure

Concomitant use with other antihypertensive agents (e.g., diuretics like furosemide) increases the risk of hypotension. Caution is also advised with medications for erectile dysfunction (PDE5 inhibitors), which can also lower blood pressure.

Drug Interactions Affecting Metabolism

Cozaar is metabolized by cytochrome P450 enzymes CYP2C9 and CYP3A4. Drugs that inhibit these enzymes, such as the antifungal fluconazole, can increase plasma concentrations of losartan. Inducers of these enzymes may decrease its concentration.

Cozaar Dosage Information

The ranges below are educational examples from prescribing information and are not instructions for starting, changing, or stopping therapy without medical supervision.

Dosage must be individualized. The following table provides general guidelines for the approved indications. In prescribing information, a common starting dose for hypertension in adults is 50 mg once daily; the prescriber selects the dose based on patient factors and response.

Important Administration Notes

• Pediatric Hypertension (≥6 years): Dose is based on weight. The recommended starting dose in prescribing information is 0.7 mg per kg once daily (up to 50 mg total), with clinician-directed adjustments.
• Maximum Dose: The maximum recommended daily dose is 100 mg for most indications.
• Onset and Duration: The antihypertensive effect is attained within 1 week and maximal reduction is generally achieved after 3 to 6 weeks of therapy.

Drug Interactions with Cozaar

Cozaar interacts with several common medications and substances. Always inform your healthcare provider of all products you are using.

Additional Information

Storage and Handling

Store Cozaar tablets at room temperature between 20°C to 25°C (68°F to 77°F), in a tightly closed container, and protect from light. Keep all medications out of the reach of children and pets.

Mechanism of Action and Unique Properties

Losartan selectively blocks the angiotensin II type 1 (AT1) receptor. Its active metabolite is more potent than the parent drug and contributes substantially to the antihypertensive effect. Unlike other ARBs, losartan has a mild uricosuric effect, meaning it can increase the excretion of uric acid and may modestly lower serum uric acid levels.

Reporting Side Effects

You are encouraged to report negative side effects of prescription drugs to the U.S. Food and Drug Administration (FDA) via the MedWatch program. Reporting helps the FDA monitor the safety of medications.

References and Medical Sources

The information on this page is based on official prescribing information and authoritative clinical resources.

1. U.S. Food and Drug Administration (FDA). Cozaar (losartan potassium) Tablets Prescribing Information. [Revised 2018]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020386s062lbl.pdf
2. MedlinePlus. Losartan. U.S. National Library of Medicine; [Updated 2022]. https://medlineplus.gov/druginfo/meds/a695008.html
3. American Heart Association (AHA). Understanding Blood Pressure Medications. https://www.heart.org/en/health-topics/high-blood-pressure/changes-you-can-make-to-manage-high-blood-pressure/types-of-blood-pressure-medications
4. Drugs.com. Losartan Professional Monograph. Drugs.com; [Updated 2024]. https://www.drugs.com/monograph/losartan-potassium.html

Disclaimer: The information on this site is provided for informational purposes only and is not medical advice. It does not replace professional medical consultation, diagnosis, or treatment. Do not self-medicate based on the information presented on this site. Always consult with a doctor or other qualified healthcare professional before making any decisions about your health.